title: Safety and efficacy of ranibizumab for pregnant women in idiopathic choroidal neovascularization.
authors.affiliation: Ophthalmology Department, CHNO Quinze-Vingts, Paris, France.
authors.forename: Léa
authors.initials: L
authors.lastname: Jouve
authors.affiliation: Ophthalmology Department, CHNO Quinze-Vingts, Paris, France.
authors.forename: Jad
authors.initials: J
authors.lastname: Akesbi
authors.affiliation: Ophthalmology Department, CHNO Quinze-Vingts, Paris, France.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Nordmann
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D011247:Pregnancy; D000069579:Ranibizumab / Q000009:adverse effects / Q000627:therapeutic use*; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab